Asha Nair

Asha Nair, MD

Assistant in Cardiology

Instructor of Pediatrics, Harvard Medical School

    Contact: (617)355-7856
  • Fax: (617)713-3808

"My clinical and research interests include anticoagulation in the cardiac ICU, mechanical circulatory support, and the care of neonates with cardiac disease."

Medical Services

Specialties

  • Cardiac critical care
  • Cardiology
  • Critical Care
  • Anticoagulation

Departments

  • Cardiology

Languages

  • English

Programs

  • Cardiac Intensive Care Unit
  • Cardiovascular Program
To schedule an appointment: Call (617)355-7856

Experience and Education

Education

Medical Degree

Albany Medical College, 2008

Albany, NY

Internship - Pediatrics

UMDNJ-Robert Wood Johnson University Hospital, 2011

New Brunswick, NJ

Residency - Pediatrics

UMDNJ-Robert Wood Johnson University Hospital, 2011

New Brunswick, NJ

Fellowship - Pediatric Cardiology

Children's National Medical Center, 2015

Washington, DC

Fellowship - Cardiovascular Critical Care

Boston Children's Hospital, 2016

Boston, MA

Certifications

  • American Board of Pediatrics

Professional History

After completing my medical training at Albany Medical College, I entered pediatric residency training at Robert Wood Johnson University Hospital. I spent one year working in the Neonatal Intensive Care Unit at Morgan Stanley Children’s Hospital of Columbia University Medical Center, focusing on the care of neonates with congenital heart disease. Prior to coming on staff, I completed pediatric cardiology fellowship at Children’s National Medical Center in D.C, followed by a senior fellowship in cardiovascular critical care here at Boston Children’s Hospital. My clinical and research interests include anticoagulation in the cardiac ICU, mechanical circulatory support, and the care of neonates with cardiac disease.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Sarmento O, Xiong Y, Sun Z, Svingen P, Bamidele A, Smyrk T, Nair A, Baheti S, McGovern D, Friton J, Papadakis K, Goel G, Xavier R, Urrutia R, Faubion W. O-015 YI Alterations in the FOXP3-EZH2 Pathway Associates with Increased Susceptibility to Colitis in Both Mice and Human. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S5-6.
  2. Larson NB, McDonnell S, French AJ, Fogarty Z, Cheville J, Middha S, Riska S, Baheti S, Nair AA, Wang L, Schaid DJ, Thibodeau SN. Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression. Am J Hum Genet. 2015 Jun 4; 96(6):869-82.
  3. Kalari KR, Nair AA, Bhavsar JD, O'Brien DR, Davila JI, Bockol MA, Nie J, Tang X, Baheti S, Doughty JB, Middha S, Sicotte H, Thompson AE, Asmann YW, Kocher JP. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinformatics. 2014 Jun 27; 15:224.
  4. Sun Z, Asmann YW, Nair A, Zhang Y, Wang L, Kalari KR, Bhagwate AV, Baker TR, Carr JM, Kocher JP, Perez EA, Thompson EA. Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol. PLoS One. 2013; 8(8):e71745.
  5. Asmann YW, Middha S, Hossain A, Baheti S, Li Y, Chai HS, Sun Z, Duffy PH, Hadad AA, Nair A, Liu X, Zhang Y, Klee EW, Kalari KR, Kocher JP. TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data. Bioinformatics. 2012 Jan 15; 28(2):277-8.
  6. Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, Munz JM, Kosari F, Vasmatzis G. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. Cancer Res. 2010 Nov 15; 70(22):8994-9002.
  7. Kalari KR, Rossell D, Necela BM, Asmann YW, Nair A, Baheti S, Kachergus JM, Younkin CS, Baker T, Carr JM, Tang X, Walsh MP, Chai HS, Sun Z, Hart SN, Leontovich AA, Hossain A, Kocher JP, Perez EA, Reisman DN, Fields AP, Thompson EA. Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations. Front Oncol. 2012; 2:12.
To schedule an appointment: Call (617)355-7856

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close